Nyumbani › Uharibifu wa Makula
Majaribio ya kliniki ya Uharibifu wa Makula yanayovutia washiriki nchini Marekani
Masomo 55 ya Uharibifu wa Makula yanavutia washiriki katika vituo vya Marekani nzima.
Miji yenye masomo mengi
- Dallas, TXUtafiti 13
- Erie, PAUtafiti 10
- The Woodlands, TXUtafiti 9
- Sacramento, CAUtafiti 8
- Hagerstown, MDUtafiti 8
- Reno, NVUtafiti 8
- Phoenix, AZUtafiti 7
- Cleveland, OHUtafiti 7
- Houston, TXUtafiti 7
- Salt Lake City, UTUtafiti 7
- Boston, MAUtafiti 7
- Austin, TXUtafiti 7
- Carmel, INUtafiti 7
- Fort Worth, TXUtafiti 7
- Santa Monica, CAUtafiti 7
- Washington, DCUtafiti 6
- Cincinnati, OHUtafiti 6
- McAllen, TXUtafiti 6
- Philadelphia, PAUtafiti 6
- Mountain View, CAUtafiti 6
- Portland, ORUtafiti 6
- Columbia, SCUtafiti 6
- Nashville, TNUtafiti 6
- Raleigh, NCUtafiti 6
- Naperville, ILUtafiti 6
- Durham, NCUtafiti 5
- Spokane, WAUtafiti 5
- Pensacola, FLUtafiti 5
- Fort Lauderdale, FLUtafiti 5
- Tampa, FLUtafiti 5
- Eugene, ORUtafiti 5
- Syracuse, NYUtafiti 5
- Lynchburg, VAUtafiti 5
- San Francisco, CAUtafiti 5
- Orlando, FLUtafiti 5
- San Antonio, TXUtafiti 5
- Sarasota, FLUtafiti 4
- Ann Arbor, MIUtafiti 4
- Memphis, TNUtafiti 4
- Jacksonville, FLUtafiti 4
Kwa jimbo
- ArizonaUtafiti 11
- CaliforniaUtafiti 20
- ColoradoUtafiti 7
- ConnecticutUtafiti 6
- FloridaUtafiti 14
- GeorgiaUtafiti 6
- IllinoisUtafiti 13
- IndianaUtafiti 7
- MarylandUtafiti 11
- MassachusettsUtafiti 14
- MichiganUtafiti 9
- MinnesotaUtafiti 5
- MississippiUtafiti 5
- MissouriUtafiti 5
- NevadaUtafiti 8
- New JerseyUtafiti 7
- New YorkUtafiti 10
- North CarolinaUtafiti 11
- OhioUtafiti 11
- OklahomaUtafiti 3
- OregonUtafiti 9
- PennsylvaniaUtafiti 17
- South CarolinaUtafiti 8
- TennesseeUtafiti 7
- TexasUtafiti 24
- UtahUtafiti 9
- VirginiaUtafiti 7
- WashingtonUtafiti 8
- WisconsinUtafiti 6
Masomo yaliyosasishwa hivi karibuni
Maandishi rasmi ya utafiti (Kiingereza)
National Eye Institute Biorepository for Retinal Diseases
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 2 hadi 120 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT01496625A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
InaajiriHatua 2/3
Umri 50 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07440225A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
InaajiriHatua 2/3
Umri 60 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT06635148A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
InaajiriHatua 1/2
Umri 55 na zaidi · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT07029945Cell Collection to Study Eye Diseases
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
1 Day – 120 Years · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT01432847A Study in Adults With Geographic Atrophy
InaajiriHatua 2
Umri 60 na zaidi · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
InaajiriHatua 3
Umri 50 hadi 85 · Jinsia zote · Imesasishwa 18 Sep 2026 · NCT06541704A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
InaajiriHatua 1
Umri 6 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT07734064The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT06319872A Phase 2 Study of NT-101 Topical in Patients With Wet AMD
InaajiriHatua 2
Umri 50 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT07811726Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
InaajiriHatua 2
Umri 55 na zaidi · Jinsia zote · Imesasishwa 10 Sep 2026 · NCT06659445Noninvasive Imaging Biomarkers of Treatable Macrovascular Disease in Age-related Macular Degeneration.
InaajiriUtafiti wa uchunguzi
Umri 50 hadi 80 · Jinsia zote · Imesasishwa 3 Sep 2026 · NCT07798323A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
InaajiriHatua 1
Umri 50 na zaidi · Jinsia zote · Imesasishwa 3 Sep 2026 · NCT03178149A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
InaajiriUtafiti wa uchunguzi
Umri 55 na zaidi · Jinsia zote · Imesasishwa 3 Sep 2026 · NCT07144137Effect of Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation on Skin Carotenoid Concentration: A Six-Month, Placebo-Controlled Crossover Study
InaajiriWajitolea wenye afya wanakaribishwa
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Sep 2026 · NCT06965426A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
InaajiriUtafiti wa uchunguzi
Umri 50 na zaidi · Jinsia zote · Imesasishwa 1 Sep 2026 · NCT06346600SGLT2 Inhibitors in Geographic Atrophy
InaajiriHatua 2
Umri 50 na zaidi · Jinsia zote · Imesasishwa 26 Ago 2026 · NCT07174687Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
Inaajiri
Umri 60 na zaidi · Jinsia zote · Imesasishwa 26 Ago 2026 · NCT06662162A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
InaajiriUtafiti wa uchunguzi
Umri 6 na zaidi · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT074255744D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
InaajiriHatua 1/2
Umri 50 na zaidi · Jinsia zote · Imesasishwa 21 Ago 2026 · NCT05197270A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
InaajiriHatua 2
Umri 55 na zaidi · Jinsia zote · Imesasishwa 20 Ago 2026 · NCT06659549Phase 1 Study of C.001 in Retinal Degeneration
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 17 Ago 2026 · NCT07594236AMD and Validation Rod-Meditated Dark Adaptation With Everyday Task Performance
InaajiriWajitolea wenye afya wanakaribishwa
Umri 50 hadi 89 · Jinsia zote · Imesasishwa 10 Ago 2026 · NCT06619405A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
InaajiriHatua 2/3
Umri 50 na zaidi · Jinsia zote · Imesasishwa 6 Ago 2026 · NCT07496567Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
InaajiriHatua 1
Umri 50 na zaidi · Jinsia zote · Imesasishwa 5 Ago 2026 · NCT07230834Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.